Exploristics are delighted to announce the launch of the Spring 2022 release of our revolutionary clinical trial simulation software, KerusCloud.
Building on KerusCloud’s established ground-breaking simulation capabilities and in response to extensive user feedback, the latest release offers a transformative range of new and improved features to deliver exceptional data-driven design.
Find out more about how KerusCloud 2022 is improving the current clinical trial design process to extensively optimise and de-risk studies by supporting earlier strategic statistical input.
You can also browse a selection of KerusCloud case studies, view the platform through our new KerusCloud Playground or book a free live one-to-one demo to see what it can do for yourself.
Exploristics are delighted to announce the launch of the Spring 2022 release of our revolutionary clinical trial simulation software, KerusCloud.
Building on KerusCloud’s established ground-breaking capabilities and in response to extensive user feedback, the latest release offers a transformative range of new and improved features to deliver exceptional data-driven design.
To find out more about KerusCloud 2022’s new features and how study simulation software is improving the current clinical trial design process with earlier strategic statistical input that extensively optimises and de-risk studies, please join us for a free live webinar on ‘Revolutionising clinical trial design with in silico studies using synthetic patient level data’ on Wednesday 22nd June 2022 at 3pm BST.
You can also browse a selection of KerusCloud case studies, view the platform through our new KerusCloud Playground or book a free live one-to-one demo to see what it can do for yourself.
Introducing KerusCloud 2022
Introducing KerusCloud 2022
Exploristics are delighted to announce the launch of the Spring 2022 release of our revolutionary clinical trial simulation software, KerusCloud.
Building on KerusCloud’s established ground-breaking capabilities and in response to extensive user feedback, the latest release offers a transformative range of new and improved features to deliver exceptional data-driven design.
To find out more about KerusCloud 2022’s new features and how study simulation software is improving the current clinical trial design process with earlier strategic statistical input that extensively optimises and de-risk studies, please join us for a free live webinar on ‘Revolutionising clinical trial design with in silico studies using synthetic patient level data’ on Wednesday 22nd June 2022 at 3pm BST.
You can also browse a selection of KerusCloud case studies, view the platform through our new KerusCloud Playground or book a free live one-to-one demo to see what it can do for yourself.
What’s new for Spring 2022
KerusCloud 2022 product enhancements include:
Adaptive Designs
Compare fixed with adaptive study designs including Futility, Group Sequential and Sample Size Re-estimation
to identify the design type that best suits project needs.
More Analysis
Assess the performance of more statistical analysis strategies, including the Cochran-Mantel-Haenszel test (CMH), Poisson Regression Analysis with Dispersion, and ANOVA tests with optional adjustment methods, to control for sources of bias and pinpoint the best analysis approach.
Decision Criteria
Improve decision-making by exploring more decision criteria to quantify and define study success, such as multiplicity adjustments to p-values and odds ratio for Logistic regression, controlling false positive rates in both exploratory and regulatory studies
Imputation
Evaluate estimands and imputation strategies for more realistic simulated study scenarios that closely mimic data quirks such as missingness and the intercurrent events found in real clinical studies.
Enhanced Heatmapping
Visualise results with a new heatmap that delivers a more detailed breakdown of analysis and adaptive design data to provide in-depth information on simulated scenario performance and facilitate study design decision-making.
Output Reporting
Share key project information across distributed teams with new downloadable pdf reports detailing virtual population models, study designs, analyses, decision criteria and a bibliography of references used for data sourcing.
